Acute Lymphoblastic Leukemia Cancer from Diagnosis to Treatment
What is Acute Lymphoblastic Leukemia?
Acute lymphoblastic leukemia is a cancer of the blood and bone marrow - the soft tissue inside bones where blood cells are made.
It occurs when the bone marrow produces too many immature white blood cells | called lymphoblasts.
These abnormal cells crowd out healthy blood cells, leading to problems with infection, anemia, and bleeding.
ALL is the most common type of childhood cancer, but it can also occur in adults.
Acute lymphoblastic leukemia is a cancer of the blood and bone marrow - the soft tissue inside bones where blood cells are made.
It occurs when the bone marrow produces too many immature white blood cells | called lymphoblasts.
These abnormal cells crowd out healthy blood cells, leading to problems with infection, anemia, and bleeding.
ALL is the most common type of childhood cancer, but it can also occur in adults.
1. Early Signs and Symptoms
• Fatigue and weakness | due to anemia
• Frequent infections | due to low white cell function
• Easy bruising or bleeding | from low platelets
• Fever and night sweats
• Bone or joint pain
• Swollen lymph nodes, especially in the neck, armpits, or groin
• Abdominal swelling | from an enlarged liver or spleen
• Shortness of breath or chest pain | if the thymus is affected
• Fatigue and weakness | due to anemia
• Frequent infections | due to low white cell function
• Easy bruising or bleeding | from low platelets
• Fever and night sweats
• Bone or joint pain
• Swollen lymph nodes, especially in the neck, armpits, or groin
• Abdominal swelling | from an enlarged liver or spleen
• Shortness of breath or chest pain | if the thymus is affected
2. Causes and Risk Factors
The exact cause of ALL is not known, but several factors increase risk
• Genetic mutations or chromosomal abnormalities
• Previous chemotherapy or radiation therapy
• Exposure to high radiation or certain chemicals | like benzene
• Certain genetic disorders | Down syndrome
• Family history of blood cancers
The exact cause of ALL is not known, but several factors increase risk
• Genetic mutations or chromosomal abnormalities
• Previous chemotherapy or radiation therapy
• Exposure to high radiation or certain chemicals | like benzene
• Certain genetic disorders | Down syndrome
• Family history of blood cancers
3. Diagnostic Procedure
The diagnosis usually involves several steps
Physical Examination
The doctor checks for swollen lymph nodes, enlarged liver or spleen, and signs of anemia or infection.
Imaging Tests
Chest X-ray, CT, or MRI may be done to check for organ involvement or enlarged lymph nodes.
Bone Marrow Aspiration and Biopsy
A small sample of bone marrow is examined to confirm the diagnosis and determine the percentage of blast cells.
Blood Tests
Complete Blood Count:
Shows abnormal levels of white cells, red cells, and platelets.
Peripheral Blood Smear:
Reveals immature lymphoblasts under a microscope.
Cytogenetic and Molecular Tests
Used to identify genetic abnormalities.
Helps classify ALL and plan treatment.
Lumbar Puncture | Spinal Tap
Checks if leukemia cells have spread to the brain or spinal fluid.
The diagnosis usually involves several steps
Physical Examination
The doctor checks for swollen lymph nodes, enlarged liver or spleen, and signs of anemia or infection.
Imaging Tests
Chest X-ray, CT, or MRI may be done to check for organ involvement or enlarged lymph nodes.
Bone Marrow Aspiration and Biopsy
A small sample of bone marrow is examined to confirm the diagnosis and determine the percentage of blast cells.
Blood Tests
Complete Blood Count:
Shows abnormal levels of white cells, red cells, and platelets.
Peripheral Blood Smear:
Reveals immature lymphoblasts under a microscope.
Cytogenetic and Molecular Tests
Used to identify genetic abnormalities.
Helps classify ALL and plan treatment.
Lumbar Puncture | Spinal Tap
Checks if leukemia cells have spread to the brain or spinal fluid.
4. Classification of ALL
ALL is classified based on the type of lymphocyte affected.
B-cell | most common
T-cell | less common, often with a large thymus mass
ALL is classified based on the type of lymphocyte affected.
B-cell | most common
T-cell | less common, often with a large thymus mass
5. Treatment Options
➛ Induction Therapy
The goal is to kill most of the leukemia cells and achieve remission.
Drugs often used:
Vincristine
Dexamethasone/Prednisone
Daunorubicin
L-asparaginase.
➛ Consolidation | Intensification | Therapy
Prevents remaining leukemia cells from growing.
Uses high-dose chemotherapy or targeted therapy.
➛ Maintenance Therapy
Lower-dose chemotherapy for 2-3 years to maintain remission.
Common drugs:
Methotrexate
6-mercaptopurine
Vincristine
Prednisone.
➛ Central Nervous System Prophylaxis
Prevents leukemia from spreading to the brain or spinal cord.
May include intrathecal chemotherapy or CNS radiation.
➛ Targeted Therapy
For ALL with genetic changes like the Philadelphia chromosome (Ph+), drugs such as imatinib, dasatinib, or nilotinib are used.
➛ Immunotherapy
CAR T-cell therapy uses the patient’s own immune cells to attack leukemia cells.
Monoclonal antibodies help target leukemia cells.
➛ Stem Cell | Bone Marrow | Transplant
Considered for patients with relapsed or high-risk ALL.
Healthy donor stem cells replace the diseased bone marrow after high-dose chemotherapy or radiation.
➛ Induction Therapy
The goal is to kill most of the leukemia cells and achieve remission.
Drugs often used:
Vincristine
Dexamethasone/Prednisone
Daunorubicin
L-asparaginase.
➛ Consolidation | Intensification | Therapy
Prevents remaining leukemia cells from growing.
Uses high-dose chemotherapy or targeted therapy.
➛ Maintenance Therapy
Lower-dose chemotherapy for 2-3 years to maintain remission.
Common drugs:
Methotrexate
6-mercaptopurine
Vincristine
Prednisone.
➛ Central Nervous System Prophylaxis
Prevents leukemia from spreading to the brain or spinal cord.
May include intrathecal chemotherapy or CNS radiation.
➛ Targeted Therapy
For ALL with genetic changes like the Philadelphia chromosome (Ph+), drugs such as imatinib, dasatinib, or nilotinib are used.
➛ Immunotherapy
CAR T-cell therapy uses the patient’s own immune cells to attack leukemia cells.
Monoclonal antibodies help target leukemia cells.
➛ Stem Cell | Bone Marrow | Transplant
Considered for patients with relapsed or high-risk ALL.
Healthy donor stem cells replace the diseased bone marrow after high-dose chemotherapy or radiation.
6. Follow-Up
➛ Blood tests, Bone marrow exams, and Monitoring for relapse.
➛ Long-term care includes management of side effects and ensuring normal growth and development in children.
➛ Blood tests, Bone marrow exams, and Monitoring for relapse.
➛ Long-term care includes management of side effects and ensuring normal growth and development in children.
Read More
➛ Step by Step Overview
➛ Patient's Appeal
➛ Patients’ Stories
➛ Transparency Page
➛ Volunteer / Partner Page